Johanna Mercier - 10 Jun 2025 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Chief Commercial Officer
Signature
/s/ Edward S. Son by Power of Attorney for Johanna Mercier
Issuer symbol
GILD
Transactions as of
10 Jun 2025
Net transactions value
-$201,134
Form type
4
Filing time
11 Jun 2025, 18:58:38 UTC
Previous filing
23 May 2025
Next filing
17 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mercier Johanna Chief Commercial Officer GILEAD SCIENCES, INC., 333 LAKESIDE DRIVE, FOSTER CITY /s/ Edward S. Son by Power of Attorney for Johanna Mercier 11 Jun 2025 0001782135

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +3,843 +3.2% 124,995 10 Jun 2025 Direct F1
transaction GILD Common Stock Tax liability $201,134 -1,827 -1.5% $110.09 123,168 10 Jun 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -3,843 -9.8% 35,360 10 Jun 2025 Common Stock 3,843 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.